XYY male with essential thrombocythemia in childhood.
We describe a boy with XYY male accompanied with essential thrombocythemia. This is, to our knowledge, the first complete case report of the kind in the pediatric literature. The patient was asymptomatic, but at age 5 his platelet count had increased to 145.5 x 10(4)/microL, and he was diagnosed as having essential thrombocythemia based on the diagnostic criteria of the Polycythemia Vera Study Group. At that time, it was discovered by chromosome analysis of both bone marrow and peripheral blood cells that he was XYY male. At times during the clinical course when his platelet count was 94.1 x 10(4)/microL, his serum thrombopoietin (measured by enzyme-linked immunosorbent assay) was 1.09 fmol/mL, which was normal for his age. Aspirin was administered, and he remained asymptomatic throughout the course. After 2 years, he underwent a spontaneous remission. Because of the small number of reported cases, we have been unable to determine the relation between XYY males and essential thrombocythemia.
Okada
H
H
Department of Pediatrics, Kagawa Medical University, Japan.
Imai
T
T
Itoh
S
S
Isobe
K
K
Onishi
S
S
D001241:Aspirin / Q000008:administration & dosage; D001773:Blood Cells / Q000473:pathology / Q000648:ultrastructure; D001854:Bone Marrow Cells / Q000473:pathology / Q000648:ultrastructure; D002675:Child, Preschool; D018572:Disease-Free Survival; D006801:Humans; D008297:Male; D010976:Platelet Count; D013922:Thrombocytosis / Q000188:drug therapy / Q000235:genetics*; D014997:XYY Karyotype / Q000097:blood* / Q000473:pathology
D001241:Aspirin